A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the only vaccine for humans against Lyme disease. “Lyme disease can cause potentially serious consequences – where individuals and families face…
Lyme disease vaccine 70 percent effective: Pfizer
Originally reported by The Hill
Related Articles
Lawsuit Argues Trump’s $1.8 Billion Fund Excludes Those He Targeted
The constellation of individuals and groups involved claims to have suffered partisan attacks by the federal government ...
Schiff: Gabbard’s resignation ‘only positive contribution’ to US security
Sen. Adam Schiff (D-Calif.) said Director of National Intelligence (DNI) Tulsi Gabbard’s decision to resign Friday was t...
Pratt: Bass concern over AI ads ‘funniest thing I’ve ever heard’
Los Angeles mayoral candidate Spencer Pratt on Wednesday dismissed Mayor Karen Bass’s concern over violence i...
Cruz on Blanche’s Senate GOP meeting: ‘Fireworks at an epic level’
Sen. Ted Cruz (R-Texas) says that about half the Senate Republican Conference blasted acting Attorney General Todd Blanc...